Overview of drug treatment Lenalidomide (Revlimid®) for bone marrow cancer patients in Australia
Lenalidomide (Revlimid) is a treatment plan that is part of IMiD class of drugs; IMiD in full refers to immunomodulatory drug. The term is particularly used to describe drugs that are consumed orally that are structurally related to thalidomide. The drugs have been structured to […]